![Asia-Pacific Roundup: Philippine FDA seeks feedback on abridged procedures for clinical trial applic | RAPS Asia-Pacific Roundup: Philippine FDA seeks feedback on abridged procedures for clinical trial applic | RAPS](https://www.raps.org/RAPS/media/news-images/recon%20and%20roundups/Asia-Pac-Roundup-300x250-2022.png?ext=.png?maxsidesize=100)
Asia-Pacific Roundup: Philippine FDA seeks feedback on abridged procedures for clinical trial applic | RAPS
![Press Statement || Updates on Applications for Conduct of Clinical Trials and Emergency Use Authorization of COVID-19 Vaccines - Food and Drug Administration Press Statement || Updates on Applications for Conduct of Clinical Trials and Emergency Use Authorization of COVID-19 Vaccines - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/02/Updates-on-Applications-for-Conduct-of-Clinical-Trials-and-Emergency-Use-Authorization-of-COVID-19-Vaccines.png)
Press Statement || Updates on Applications for Conduct of Clinical Trials and Emergency Use Authorization of COVID-19 Vaccines - Food and Drug Administration
![Department of Health on Twitter: "#ChecktheFAQs! Q: Is there a cure for COVID-19? Why are we vaccinating for this disease? A: There is currently no licensed medication to cure COVID-19. However, there Department of Health on Twitter: "#ChecktheFAQs! Q: Is there a cure for COVID-19? Why are we vaccinating for this disease? A: There is currently no licensed medication to cure COVID-19. However, there](https://pbs.twimg.com/media/EzfukqNXEAITrOH.jpg)
Department of Health on Twitter: "#ChecktheFAQs! Q: Is there a cure for COVID-19? Why are we vaccinating for this disease? A: There is currently no licensed medication to cure COVID-19. However, there
![FDA Circular No.2020-029-A || Amendment to FDA Circular No. 2020-029 entitled “Guidance on Applications for the Conduct of COVID-19 Clinical Trials” - Food and Drug Administration FDA Circular No.2020-029-A || Amendment to FDA Circular No. 2020-029 entitled “Guidance on Applications for the Conduct of COVID-19 Clinical Trials” - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2022/04/FDA-Circular-No.-2020-029-A.jpg)
FDA Circular No.2020-029-A || Amendment to FDA Circular No. 2020-029 entitled “Guidance on Applications for the Conduct of COVID-19 Clinical Trials” - Food and Drug Administration
![Draft for Comments || Guidelines on Regulatory Reliance on the Conduct of Clinical Trials in the Philippines - Food and Drug Administration Draft for Comments || Guidelines on Regulatory Reliance on the Conduct of Clinical Trials in the Philippines - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2022/08/Draft-for-Comments_Guidelines-on-Regulatory-Reliance-on-the-Conduct-of-Clinical-Trials-in-the-Philippines.png)
Draft for Comments || Guidelines on Regulatory Reliance on the Conduct of Clinical Trials in the Philippines - Food and Drug Administration
![Administrative Order No. 2020-0010 || Regulations on the Conduct of Clinical Trials for Investigational Products - Food and Drug Administration Administrative Order No. 2020-0010 || Regulations on the Conduct of Clinical Trials for Investigational Products - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/02/Administrative-Order-No.2020-0010.jpg)
Administrative Order No. 2020-0010 || Regulations on the Conduct of Clinical Trials for Investigational Products - Food and Drug Administration
![Novartis renews partnership with Philippine Heart Center as Center of Excellence in Clinical Trials | Novartis Philippines Novartis renews partnership with Philippine Heart Center as Center of Excellence in Clinical Trials | Novartis Philippines](https://www.novartis.com/ph-en/sites/novartis_ph/files/styles/crop_freeform/public/2022-03/CARL7225.jpg?itok=u_ui97RA)